Acrux announced that Tim Bateman has been appointed to the role of Chief Financial Officer and Company Secretary. Tim replaces Sharon Papworth who has resigned and will leave the company on 28 October 2016. Tim is an experienced CFO with a broad background as a Chartered Accountant in senior management roles in listed international entities and their subsidiaries.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | 0.00% | -1.52% | +47.73% |
04-03 | Acrux, TruPharma Launch Dapsone 5% Gel in US | MT |
02-29 | Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.73% | 12.59M | |
+17.06% | 42.25B | |
+15.22% | 21.27B | |
+19.33% | 15.23B | |
+19.07% | 14.36B | |
+50.32% | 12.74B | |
-0.05% | 6.79B | |
-12.16% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- ACR Stock
- News Acrux Limited
- Acrux Announces Executive Changes, Effective 28 October 2016